Safety and efficacy of riluzole in spinocerebellar ataxia type 2 in France (ATRIL): a multicentre, randomised, double-blind, placebo-controlled trial Article Publication Date 18-Jan-2022 ...

The study was conducted between Jan. 18, 2018, and June 14, 2019, and included 45 participants with spinocerebellar ataxia type 2, with age of onset up to 50 years.

Patients with ataxia lose control of their muscles, which can for example affect how they move or talk. An extremely rare form of this disease is episodic ataxia type 6 (EA6), in which patients ...